TY  - GEN
N2  - This book illustrates the significance and relevance of immunotherapy in modern-day therapeutics. Focusing on the application of immunotherapy in oncology, neurodegenerative and autoimmune diseases, it discusses the drug delivery systems, and pre-clinical and clinical methodologies for immunotherapy-based drugs. It also comprehensively reviews various aspects of immunotherapy, such as regulatory affairs, quality control, safety, and pharmacovigilance. Further, the book discusses the in vitro validation of therapeutic strategies prior to patient application and management of immunotherapy-related side effects and presents case studies demonstrating the design and development (pre-clinical to clinical) of immunotherapy for various diseases. It also describes various design considerations and the scale-up synthesis of immunotherapeutics and screening methods. Lastly, it explores the important aspect of cost-effectiveness and rational immunotherapy strategies.
DO  - 10.1007/978-981-15-9038-2
DO  - doi
AB  - This book illustrates the significance and relevance of immunotherapy in modern-day therapeutics. Focusing on the application of immunotherapy in oncology, neurodegenerative and autoimmune diseases, it discusses the drug delivery systems, and pre-clinical and clinical methodologies for immunotherapy-based drugs. It also comprehensively reviews various aspects of immunotherapy, such as regulatory affairs, quality control, safety, and pharmacovigilance. Further, the book discusses the in vitro validation of therapeutic strategies prior to patient application and management of immunotherapy-related side effects and presents case studies demonstrating the design and development (pre-clinical to clinical) of immunotherapy for various diseases. It also describes various design considerations and the scale-up synthesis of immunotherapeutics and screening methods. Lastly, it explores the important aspect of cost-effectiveness and rational immunotherapy strategies.
T1  - Immunotherapy -- a novel facet of modern therapeutics /
DA  - 2021.
CY  - Singapore :
AU  - Sawarkar, Sujata P.
AU  - Nikam, Vandana S.
AU  - Syed, Shariq.
CN  - RM275
PB  - Springer,
PP  - Singapore :
PY  - 2021.
ID  - 1432975
KW  - Immunotherapy.
KW  - Immunothérapie.
SN  - 9789811590382
SN  - 9811590389
TI  - Immunotherapy -- a novel facet of modern therapeutics /
LK  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-15-9038-2
UR  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-15-9038-2
ER  -